AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests
July 28, 2014 at 02:00 AM EDT
LONDON, July 28 (Reuters) - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.
